Program
Sinovac PCV24 formulation 1
Also written as “Sinovac PCV24 formulation 2” and “Sinovac PCV24”.
Its studies are mostly in Pneumococcal Infections, led by Sinovac Biotech.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sinovac Biotech | 42 open or running | phase 2since Nov 24, 2025 | Jun 19, 2024 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 19, 2024First study: phase 1 study in Pneumococcal InfectionsFirst studyNCT06474377 · 170 enrolled · China
- Aug 8, 2024Phase 1 study in Pneumococcal InfectionsNCT06550830 · 119 enrolled · China
- Jan 23, 2025Phase 1 study in Pneumococcal InfectionsNCT06800261 · 180 planned · China
- Nov 24, 2025Phase 2 study in Pneumococcal InfectionsPhase 2 reachedNCT07300644 · 420 planned · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07300644Pneumococcal Infections · China | 2 | Recruiting | Sep 2026 | 420 |
| NCT06800261Pneumococcal Infections · China | 1 | Recruiting | Jun 2026 | 180 |
| NCT06550830Pneumococcal Infections · China | 1 | Completed | Jun 25, 2025 | 119 |
| NCT06474377Pneumococcal Infections · China | 1 | Completed | Aug 26, 2024 | 170 |
How it is read
Names in the registry
- “Sinovac PCV24 formulation 1”, 2 entries
- “Sinovac PCV24 formulation 2”, 2 entries
- “Sinovac PCV24”, 2 entries
Conditions, from the studies’ own filings
- Pneumococcal Infections, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.